239 related articles for article (PubMed ID: 33190008)
1. The effects of sumac (Rhus coriaria L.) powder supplementation in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
Kazemi S; Shidfar F; Ehsani S; Adibi P; Janani L; Eslami O
Complement Ther Clin Pract; 2020 Nov; 41():101259. PubMed ID: 33190008
[TBL] [Abstract][Full Text] [Related]
2. Sumac (Rhus coriaria L.) powder supplementation has beneficial effects on appetite in overweight/obese women with depression: A randomized controlled trial.
Hariri N; Darafshi Ghahroudi S; Jahangiri S; Ataie-Jafari A; Hosseinzadeh N; Abiri B; Saidpour A
Complement Ther Clin Pract; 2023 May; 51():101734. PubMed ID: 36753796
[TBL] [Abstract][Full Text] [Related]
3. The effect of sumac (Rhus coriaria L.) powder on insulin resistance, malondialdehyde, high sensitive C-reactive protein and paraoxonase 1 activity in type 2 diabetic patients.
Rahideh ST; Shidfar F; Khandozi N; Rajab A; Hosseini SP; Mirtaher SM
J Res Med Sci; 2014 Oct; 19(10):933-8. PubMed ID: 25538775
[TBL] [Abstract][Full Text] [Related]
4. The beneficial effects of sumac (Rhus coriaria L.) supplementation along with restricted calorie diet on anthropometric indices, oxidative stress, and inflammation in overweight or obese women with depression: A randomized clinical trial.
Hariri N; Darafshi Ghahroudi S; Jahangiri S; Borumandnia N; Narmaki E; Saidpour A
Phytother Res; 2020 Nov; 34(11):3041-3051. PubMed ID: 32940404
[TBL] [Abstract][Full Text] [Related]
5. The effect of sumac supplementation on insulin resistance, inflammation, oxidative stress, and antioxidant capacity in adults with metabolic syndrome: A randomized crossover clinical trial.
Hajhashemy Z; Mirenayat FS; Siavash M; Saneei P
Phytother Res; 2023 Apr; 37(4):1319-1329. PubMed ID: 36428227
[TBL] [Abstract][Full Text] [Related]
6. Sumac fruit supplementation improve glycemic parameters in patients with metabolic syndrome and related disorders: A systematic review and meta-analysis.
Ghafouri A; Estêvão MD; Alibakhshi P; Pizarro AB; Kashani AF; Persad E; Heydari H; Hasani M; Heshmati J; Morvaridzadeh M
Phytomedicine; 2021 Sep; 90():153661. PubMed ID: 34334274
[TBL] [Abstract][Full Text] [Related]
7. Effect of sumac powder on clinical symptoms, hyperandrogenism, inflammation, blood glucose, lipid profiles in women with polycystic ovary syndrome: A double-blind randomized clinical trial.
Afandak F; Aryaeian N; Kashanian M; Janani L; Namizadeh T; Karimi MY; Morvaridi M
Phytother Res; 2023 Jun; 37(6):2315-2325. PubMed ID: 36724890
[TBL] [Abstract][Full Text] [Related]
8. The effect of sumac (Rhus coriaria L.) supplementation on glycemic indices: A systematic review and meta-analysis of controlled clinical trials.
Mohit M; Nouri M; Samadi M; Nouri Y; Heidarzadeh-Esfahani N; Venkatakrishnan K; Jalili C
Complement Ther Med; 2021 Sep; 61():102766. PubMed ID: 34365008
[TBL] [Abstract][Full Text] [Related]
9. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
[TBL] [Abstract][Full Text] [Related]
10. Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial.
Mansour A; Mohajeri-Tehrani MR; Samadi M; Qorbani M; Merat S; Adibi H; Poustchi H; Hekmatdoost A
Nutr J; 2021 Apr; 20(1):35. PubMed ID: 33838673
[TBL] [Abstract][Full Text] [Related]
11. Propolis supplementation in obese patients with non-alcoholic fatty liver disease: effects on glucose homeostasis, lipid profile, liver function, anthropometric indices and meta-inflammation.
Nikbaf-Shandiz M; Tutunchi H; Khoshbaten M; Nazari Bonab H; Ebrahimi-Mameghani M
Food Funct; 2022 Nov; 13(22):11568-11578. PubMed ID: 36263703
[TBL] [Abstract][Full Text] [Related]
12. Potential Cardioprotective Effects of Sumac Capsule in Patients With Hyperlipidemia: A Triple-Blind Randomized, Placebo-Controlled Crossover Trial.
Asgary S; Salehizadeh L; Keshvari M; Taheri M; Spence ND; Farvid MS; Rafieian-Kopaei M; Sarrafzadegan N
J Am Coll Nutr; 2018; 37(4):286-292. PubMed ID: 29425477
[TBL] [Abstract][Full Text] [Related]
13. Effect of soy milk consumption on glycemic status, blood pressure, fibrinogen and malondialdehyde in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
Maleki Z; Jazayeri S; Eslami O; Shidfar F; Hosseini AF; Agah S; Norouzi H
Complement Ther Med; 2019 Jun; 44():44-50. PubMed ID: 31126574
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.
Moradi F; Kooshki F; Nokhostin F; Khoshbaten M; Bazyar H; Pourghassem Gargari B
J Trace Elem Med Biol; 2021 Jan; 63():126659. PubMed ID: 33045675
[TBL] [Abstract][Full Text] [Related]
15. Effects of garlic powder supplementation on insulin resistance, oxidative stress, and body composition in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial.
Sangouni AA; Mohammad Hosseini Azar MR; Alizadeh M
Complement Ther Med; 2020 Jun; 51():102428. PubMed ID: 32507439
[TBL] [Abstract][Full Text] [Related]
16. Rhus Coriaria L. (Sumac) in Patients with Hyperlipidemia; A Double Blind Randomized Clinical Trial.
Hajmohammadi Z; Shams M; Zibainejad MJ; Nimrouzi M; Fardidi P; Heydari M
Iran J Med Sci; 2016 May; 41(3 Suppl):S10. PubMed ID: 27840476
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Sumac (Rhus coriaria L.)Powder on Serum Glycemic Status, ApoB, ApoA-I and Total Antioxidant Capacity in Type 2 Diabetic Patients.
Shidfar F; Rahideh ST; Rajab A; Khandozi N; Hosseini S; Shidfar S; Mojab F
Iran J Pharm Res; 2014; 13(4):1249-55. PubMed ID: 25587314
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease.
Mahmoudi L; Asadi S; Al-Mousavi Z; Niknam R
Clin Nutr; 2021 May; 40(5):2999-3005. PubMed ID: 33341312
[TBL] [Abstract][Full Text] [Related]
19. The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial.
Zamani N; Shams M; Nimrouzi M; Zarshenas MM; Abolhasani Foroughi A; Fallahzadeh Abarghooei E; Fattahi MR
Complement Ther Med; 2018 Dec; 41():118-123. PubMed ID: 30477827
[TBL] [Abstract][Full Text] [Related]
20. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
Nutr Metab (Lond); 2019; 16():8. PubMed ID: 30705687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
